Sign in →

Test Code HIAAP 5-Hydroxyindoleacetic Acid, Plasma


Ordering Guidance


This test quantifies 5-hydroxyindoleacetic acid in plasma specimens and is comparable to testing on 24-hour and random urine specimens for the diagnosis and monitoring of intestinal carcinoid syndrome.



Necessary Information


Patient's age is required.



Specimen Required


Patient Preparation:

1. Some medications could interfere with test results. The ordering provider should decide if any medications should be stopped and when they should be restarted. If clinically feasible, discontinue the following medications at least 24 hours prior to specimen collection:

-Acetaminophen (Tylenol or generic versions)

-Tryptophan containing supplements.

2. For 24 hours prior to the collection, the patient should:

Limit the following to one serving per day:

-Fruits

-Vegetables

-Caffeinated beverages or foods

Abstain from the following:

-Nuts, especially walnuts. Plasma 5-hydroxyindoleacetic acid levels revert to baseline levels when walnuts are ingested after other foods.

 

Collection Container/Tube:

Preferred: Green top (sodium heparin)

Acceptable: Lavender top (EDTA)

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions:

1. Centrifuge at 4° C.

2. Aliquot plasma into plastic vial.

3. Send plasma frozen.


Secondary ID

619735

Useful For

Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using a plasma specimen

Method Name

Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

5-Hydroxyindoleacetic Acid, P

Specimen Type

Plasma

Specimen Minimum Volume

0.2 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Plasma Frozen (preferred) 60 days
  Refrigerated  72 hours

Reject Due To

Gross hemolysis OK
Thawing** Cold OK; Warm reject
Gross lipemia OK
Gross icterus OK

Clinical Information

Intestinal carcinoid and neuroendocrine tumors can produce excess amounts of serotonin and its degradation product, 5-hydroxyindoleacetic acid (5-HIAA). Determination of 5-HIAA in urine or plasma is used to diagnose and monitor patients with carcinoid syndrome.

 

Carcinoid syndrome is characterized by a constellation of hormonal symptoms such as abdominal pain, increased bowel movements, episodic facial flushing, bronchoconstriction, venous telangiectasia, niacin deficiency-related symptoms, and long-term complications, such as mesenteric fibrosis and carcinoid heart disease.(1)

 

Measurement of 5-HIAA in a plasma specimen can diagnose carcinoid disease and produces comparable results to urinary 5-HIAA testing.

Reference Values

≤6 months: ≤130 ng/mL

>6 months: ≤30 ng/mL

Interpretation

If pharmacological and dietary artifacts have been ruled out, an elevated concentration of 5-hydroxyindoleacetic acid is a probable indicator of the presence of a serotonin-producing tumor.

Day(s) Performed

Monday, Wednesday, Friday

Report Available

3 to 6 days

Specimen Retention Time

1 month

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

83497

LOINC Code Information

Test ID Test Order Name Order LOINC Value
HIAAP 5-Hydroxyindoleacetic Acid, P 1693-1

 

Result ID Test Result Name Result LOINC Value
619735 5-Hydroxyindoleacetic Acid, P 1693-1